skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 71,638  for All Library Resources

previous page 1 Results 2 3 4 5 next page
Refined by: subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
21
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Material Type:
Article
Add to My Research

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

The Lancet (British edition), 2019-01, Vol.393 (10166), p.31-39 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 5, 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32590-X ;PMID: 30424892

Full text available

22
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial
Material Type:
Article
Add to My Research

Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial

The Lancet (British edition), 2022-05, Vol.399 (10338), p.1876-1885 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00122-2 ;PMID: 35525255

Full text available

23
Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review
Material Type:
Article
Add to My Research

Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review

Value in health, 2018-07, Vol.21 (7), p.881 [Peer Reviewed Journal]

Copyright © 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved. ;EISSN: 1524-4733 ;DOI: 10.1016/j.jval.2017.12.019 ;PMID: 30005761

Digital Resources/Online E-Resources

24
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Material Type:
Article
Add to My Research

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2018-10, Vol.392 (10157), p.1519-1529 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32261-X ;PMID: 30291013

Full text available

25
Depression and cardiovascular disease
Material Type:
Article
Add to My Research

Depression and cardiovascular disease

Trends in cardiovascular medicine, 2015-10, Vol.25 (7), p.614 [Peer Reviewed Journal]

Published by Elsevier Inc. ;EISSN: 1873-2615 ;DOI: 10.1016/j.tcm.2015.02.002 ;PMID: 25850976

Digital Resources/Online E-Resources

26
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-01, Vol.321 (1), p.69 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2018.18269 ;PMID: 30418475

Digital Resources/Online E-Resources

27
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Material Type:
Article
Add to My Research

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention

JNCI : Journal of the National Cancer Institute, 2010-01, Vol.102 (1), p.14-25 [Peer Reviewed Journal]

The Author 2009. Published by Oxford University Press. 2010 ;Copyright Oxford Publishing Limited(England) Jan 6, 2010 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djp440 ;PMID: 20007921 ;CODEN: JNCIEQ

Full text available

28
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
Material Type:
Article
Add to My Research

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL

Journal of the American College of Cardiology, 2018-06, Vol.71 (22), p.2497-2506 [Peer Reviewed Journal]

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 5, 2018 ;info:eu-repo/semantics/openAccess ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.01.085 ;PMID: 29852973

Full text available

29
Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
Material Type:
Article
Add to My Research

Primary Prevention of Cardiovascular Disease in Diabetes Mellitus

Journal of the American College of Cardiology, 2017-08, Vol.70 (7), p.883-893 [Peer Reviewed Journal]

2017 American College of Cardiology Foundation ;Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 15, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.07.001 ;PMID: 28797359

Full text available

30
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
Material Type:
Article
Add to My Research

NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis

Journal of the American College of Cardiology, 2018-01, Vol.71 (2), p.177-192 [Peer Reviewed Journal]

2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jan 16, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.11.014 ;PMID: 29325642

Full text available

31
Meta-analysis of Cardiovascular Outcomes with Continuous Positive Airway Pressure therapy in Patients with Obstructive Sleep Apnea
Material Type:
Article
Add to My Research

Meta-analysis of Cardiovascular Outcomes with Continuous Positive Airway Pressure therapy in Patients with Obstructive Sleep Apnea

The American journal of cardiology, 2017-08, Vol.120 (4), p.693-699 [Peer Reviewed Journal]

Elsevier Inc. ;2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 15, 2017 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2017.05.042 ;PMID: 28651851

Full text available

32
Cardiorenal outcomes with dapagliflozin by baseline glucose-lowering agents: Post hoc analyses from DECLARE-TIMI 58
Material Type:
Article
Add to My Research

Cardiorenal outcomes with dapagliflozin by baseline glucose-lowering agents: Post hoc analyses from DECLARE-TIMI 58

Diabetes, obesity & metabolism, 2021-01, Vol.23 (1), p.29

2020 John Wiley & Sons Ltd. ;EISSN: 1463-1326 ;DOI: 10.1111/dom.14179 ;PMID: 32844557

Digital Resources/Online E-Resources

33
Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort
Material Type:
Article
Add to My Research

Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort

Gut, 2022-09, Vol.71 (9), p.1867-1875 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0017-5749 ;ISSN: 1468-3288 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2021-325724 ;PMID: 34489307

Full text available

34
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study
Material Type:
Article
Add to My Research

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study

Journal of the American College of Cardiology, 2018-06, Vol.71 (23), p.2628-2639 [Peer Reviewed Journal]

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. ;COPYRIGHT 2018 Elsevier B.V. ;Copyright Elsevier Limited Jun 12, 2018 ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.03.009 ;PMID: 29540325

Full text available

35
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Material Type:
Article
Add to My Research

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

The New England journal of medicine, 2015-04, Vol.372 (16), p.1489-1499 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1501031 ;PMID: 25773378

Full text available

36
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Material Type:
Article
Add to My Research

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

The Lancet (British edition), 2013-07, Vol.382 (9889), p.339-352 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 27, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60595-4 ;PMID: 23727170 ;CODEN: LANCAO

Full text available

37
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
Material Type:
Article
Add to My Research

GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data

Cardiovascular diabetology, 2018-12, Vol.17 (1), p.157-19, Article 157 [Peer Reviewed Journal]

Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-018-0800-2 ;PMID: 30545359

Full text available

38
Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review
Material Type:
Article
Add to My Research

Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2019-04, Vol.73 (14), p.1827-1845 [Peer Reviewed Journal]

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;2019. American College of Cardiology Foundation ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.01.041 ;PMID: 30975301

Full text available

39
Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2
Material Type:
Article
Add to My Research

Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2

Journal of the American College of Cardiology, 2017-11, Vol.70 (20), p.2552-2565 [Peer Reviewed Journal]

Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Nov 14, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.09.1095 ;PMID: 29145955

Full text available

40
Psychopharmacology and Cardiovascular Disease
Material Type:
Article
Add to My Research

Psychopharmacology and Cardiovascular Disease

Journal of the American College of Cardiology, 2018-05, Vol.71 (20), p.2346-2359 [Peer Reviewed Journal]

2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 22, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.03.458 ;PMID: 29773162

Full text available

Results 21 - 40 of 71,638  for All Library Resources

previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1973  (16)
  2. 1973 To 1985  (688)
  3. 1986 To 1998  (1,678)
  4. 1999 To 2012  (9,871)
  5. After 2012  (59,427)
  6. More options open sub menu

Subject 

  1. Cardiovascular Disease  (61,340)
  2. Science & Technology  (46,902)
  3. Life Sciences & Biomedicine  (41,973)
  4. Humans  (28,931)
  5. Diabetes  (19,123)
  6. Mortality  (18,954)
  7. Male  (17,764)
  8. Female  (17,366)
  9. Risk Factors  (16,734)
  10. Cardiovascular Diseases  (16,260)
  11. Coronary Vessels  (15,701)
  12. Hypertension  (15,302)
  13. Hospitals  (14,280)
  14. Middle Aged  (14,266)
  15. Heart  (14,057)
  16. Aged  (12,757)
  17. Cardiovascular System & Cardiology  (12,737)
  18. Heart Attacks  (12,083)
  19. Cardiac & Cardiovascular Systems  (11,886)
  20. More options open sub menu

Language 

  1. English  (71,523)
  2. Japanese  (3,292)
  3. Portuguese  (208)
  4. Turkish  (86)
  5. Norwegian  (72)
  6. German  (67)
  7. French  (60)
  8. Chinese  (36)
  9. Polish  (24)
  10. Spanish  (21)
  11. Italian  (7)
  12. Urdu  (5)
  13. Russian  (4)
  14. Persian  (3)
  15. Arabic  (2)
  16. Korean  (1)
  17. Dutch  (1)
  18. Bulgarian  (1)
  19. Slovenian  (1)
  20. Hindi  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait